Position in CSTL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$782,408
New position
Shares Held
31,870
first reported quarter
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Corient Private Wealth LLC holds $742,300,174 across 25 Diagnostics & Research names. CSTL ranks #18 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
832,069 | $408,986,875 | |
| 2 | DHR |
Danaher Corp /De/
|
831,925 | $157,732,979 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
122,006 | $68,553,950 | |
| 4 | A |
Agilent Technologies, Inc.
|
221,631 | $25,261,500 | |
| 5 | RVTY |
Revvity, Inc.
|
181,958 | $15,941,340 | |
| 6 | ICLR |
Icon PLC
|
115,291 | $12,758,102 | |
| 7 | ILMN |
Illumina, Inc.
|
95,466 | $11,767,139 | |
| 8 | DGX |
Quest Diagnostics Inc
|
39,325 | $7,706,912 |
All Filings in CSTL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $782,408 | 31,870 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||